Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Rachel Twomey
The DMCC Act: Consumer elements come into force from 6 April 2025
After much anticipation, it is now confirmed that next month the landmark consumer law provisions of the Digital Markets, Competition and Consumers Act (“DMCC Act”) will come into force, following the enactment of the Digital Markets, Competition and Consumers Act 2024 (Commencement No. 2) Regulations 2025 (SI 2025/272) ( “Regulations”). What provisions are coming into force? Unfair commercial practices regime: out with the old, in with the new?
Pre-pack insolvency sales: the UK approach
A “pre-pack” is a sale of all or part of a distressed company’s business or assets, negotiated before the company enters a formal insolvency process and executed by the appointed insolvency practitioner immediately after the insolvency process begins. Although there are mixed views on pre-packs, the European Commission appears to appreciate their economic merits and has taken steps towards introducing them throughout the EU.
Pre-pack insolvency sales: the UK approach
26/06/2023 A “pre-pack” is a sale of all or part of a distressed company’s business or assets, negotiated before the company enters a formal insolvency process and executed by the appointed insolvency practitioner immediately after the insolvency process begins. Although... Read more
Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus
Open Access Stuart J. Perper, Susan V. Westmoreland, Jozsef Karman, Rachel Twomey, Jane Seagal, Rui Wang, Bradford L. McRae and Stephen H. Clarke J Immunol July 1, 2019, 203 (1) 58-75; DOI: https://doi.org/10.4049/jimmunol.1900043 Key Points CD40 antagonism reverses severe proteinuria and restores glomerular morphology. CD40 antagonism normalizes nephrotic and injury-associated gene expression. CD40 antagonism disrupts multiple disease-critical immunological mechanisms.
Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus
Open Access Stuart J. Perper, Susan V. Westmoreland, Jozsef Karman, Rachel Twomey, Jane Seagal, Rui Wang, Bradford L. McRae and Stephen H. Clarke J Immunol May 20, 2019, ji1900043; DOI: https://doi.org/10.4049/jimmunol.1900043 Key Points CD40 antagonism reverses severe proteinuria and restores glomerular morphology. CD40 antagonism normalizes nephrotic and injury-associated gene expression. CD40 antagonism disrupts multiple disease-critical immunological mechanisms.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Rachel
Contact Rachel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack